• awesomeicons6/solid/lock 100% Secure Online Payments

Anti-Human PARC (CCL18)

Anti-Human PARC (CCL18) (M172-GRP)

Products

Sort by arrow-down-short-wide arrow-up-short-wide
Cat #
Size
Price
Cat # Size
chevron-left chevron-right
of

Description

Macrophage Inflammatory Protein-4 (MIP-4) produced in E.Coli is a single, non-glycosylated polypeptide that attracts lymphocytes but not monocytes or granulocytes and is involved in B cell migration into B cell follicles in lymph nodes. It attracts naive T lymphocytes toward dendritic cells and activated macrophages in lymph nodes, has chemotactic activity for naive T cells, CD4+ and CD8+ T cells and thus may play a role in both humoral and cell-mediated immunity responses. MIP-4 is expressed at high levels in lung, lymph nodes, placenta, and bone marrow, not expressed by peripheral blood monocytes, and a monocyte-to-macrophage differentiation is a prerequisite for expression.

Specifications

Manufacturer Leinco Technologies Inc
Manufacturer Cat# M172
Alternate Names Polyclonal Antibody PARC Macrophage Inflammatory Protein-4 (MIP-4) SCYA18 DC-CK1 AMAC-1 DCCK1 CKb7 CCL18 PARC Human PARC (CCL18) Anti-Human PARC (CCL18)
Target PARC
Antibody Type Polyclonal
Applications CyTOF®, FC, WB
Storage -20°C to -70°C